Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 13, 2023
ViroCell Biologics, a specialized Contract Development and Manufacturing Organization (CDMO) focused on viral vectors for cell and gene therapy clinical trials, has announced a strategic collaboration with University College London (UCL) to advance ...
read more
ViroCell Biologics announced the opening of a University College London clinical trial to advance Professor Persis Amrolia’s innovative chimeric antigen receptor (CAR) T-cell therapy for relapsed pediatric acute lymphoblastic leukemia (ALL). Dr. ...
read more
Wednesday, September 19, 2018
The Virginia Department of Criminal Justice Services announced Qlarion has been awarded a contract to construct a data-sharing and analysis platform that will improve Virginia’s response to the opioid crisis.
read more
Orphan Therapeutics Accelerator, a non-profit biotech dedicated to advancing therapies for ultra-rare conditions, announced that Viralgen has become a Contract Development and Manufacturing Organization partner within OTXL's Orphan ClinDevNet network...
read more
Thursday, February 06, 2025
Viralgen and the CTNNB1 Foundation have partnered to manufacture an investigational gene therapy designed to treat CTNNB1 Syndrome, a rare genetic disorder that affects motor and cognitive development in children.
read more
Thursday, September 30, 2021
Southeast Asia’s first GMP-compliant CDMO for viral vector manufacturing CellVec Pte Ltd announced a strategic partnership with Australia’s Peter MacCallum Cancer Centre (Peter Mac) to manufacture and supply lentiviral vectors for their in-house ...
read more
ViraCyte has been awarded $3.75M from National Institutes of Health and the FDA to advance its T cell immunotherapies.
read more
Viracor-IBT Laboratories Inc., a wholly-owned subsidiary of Eurofins Scientific, has announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay.
read more
Wednesday, March 13, 2013
Vindon Scientific have commenced manufacture of the controlled environment stability storage rooms to equip its latest storage facility in a move that forms part of Vindon’s recent drive to expand its pharmaceutical and biopharma storage operations. ...
read more
Vindon Scientific (Ireland) Ltd. have made substantial new investment in Ireland’s only IMB certified, GMP compliant Stability Storage Facility at Tramore, County Waterford. Trebling the capacity to 350m³ has enabled Vindon to offer clients stability...
read more
Thursday, August 08, 2013
Vindon, an international company specializing in controlled storage technology for the pharma and biopharma industries, has opened a new facility in Los Angeles, Southern California.
read more
Tuesday, February 27, 2024
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced positive top-line results from the company's Phase 2 clinical trial of VK2735, a dual ...
read more
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
Tuesday, November 29, 2016
Vigene Biosciences, a biotechnology company focused on viral vector production and development, has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia's cGMP facility and equipment. The ...
read more
Wednesday, October 21, 2020
Vifor and Cara announced both companies have signed a license agreement for commercialization of Korsuva (difelikefalin) Injection.
read more